NanoBio gets 3.2M, spins off NanoCure

Dec. 22, 2003 — NanoBio Corp., an Ann Arbor, Mich.-based firm specializing in nanotechnology-based pharmaceuticals, announced it has received a $3.2 million federal contract and is spinning off a company.

null

The U.S. Defense Department contract will be used to continue NanoBio’s development of its antimicrobial nanoemulsions, which incorporate nanoparticles for biodefense and drug delivery applications.

null

The company also has formed a new firm, NanoCure Corp., to commercialize dendrimer-based drug-delivery and imaging platforms. Funded by state and federal grants, NanoCure is preparing to have technology ready for clinical trials within two years, according to a company news release.

null

NanoBio and NanoCure are developing technology licensed from University of Michigan’s Center for Biologic Nanotechnology.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.